Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (451-460 of 504) with videos related to

Pageof 51
Sort By:
Blood|August 16, 2015
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli, et al.
Blood|April 16, 2025
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation: the ERIC RecommendationsAdam S Kittai, Monia Marchetti, Othman Al-Sawaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic LeukemiaRiccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia|August 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Annalisa Gaglio, Antonella Nicolò, et al.
Blood|February 4, 2021
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1Vivien Kohlhaas, Stuart James Blakemore, Mona Al-Maarri, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Haematologica|May 21, 2016
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptorsLesley-Ann Sutton, Emma Young, Panagiotis Baliakas, et al.
Hematological Oncology|May 25, 2022
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemiaGabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Leukemia|March 29, 2018
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximabMassimo Gentile, Tait D Shanafelt, Gianluigi Reda, et al.
Pageof 51

Showing results (451-460 of 504) with videos related to

Sort By:
Pageof 51
Blood|August 16, 2015
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli, et al.
Blood|April 16, 2025
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation: the ERIC RecommendationsAdam S Kittai, Monia Marchetti, Othman Al-Sawaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic LeukemiaRiccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia|August 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Annalisa Gaglio, Antonella Nicolò, et al.
Blood|February 4, 2021
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1Vivien Kohlhaas, Stuart James Blakemore, Mona Al-Maarri, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Haematologica|May 21, 2016
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptorsLesley-Ann Sutton, Emma Young, Panagiotis Baliakas, et al.
Hematological Oncology|May 25, 2022
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemiaGabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Leukemia|March 29, 2018
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximabMassimo Gentile, Tait D Shanafelt, Gianluigi Reda, et al.
Pageof 51